UCB SA Financials

UCB SA Stock Summary

UCB SA competes with Bolt Biotherapeutics, Cara Therapeutic, Arcus Biosciences, Senti Biosciences, and Cadrenal Therapeutics,. UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company was incorporated in 1925 and is headquartered in Brussels, Belgium. Ucb SA operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8600 people.

UCB SA Key Financial Ratios

There are many critical financial ratios that UCB SA's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that UCB SA reports annually and quarterly.

UCB Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining UCB SA's current stock value. Our valuation model uses many indicators to compare UCB SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across UCB SA competition to find correlations between indicators driving UCB SA's intrinsic value. More Info.UCB SA is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about  0.44  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for UCB SA is roughly  2.28 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the UCB SA's earnings, one of the primary drivers of an investment's value.

UCB SA Systematic Risk

Along with financial statement analysis, the daily predictive indicators of UCB SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of UCB SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of UCB SA based on widely used predictive technical indicators. In general, we focus on analyzing UCB Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build UCB SA's daily price indicators and compare them against related drivers.

When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.